CentraState chooses Cognizant to develop ICD-10 transition strategy

Cognizant (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process outsourcing services, today announced that it has been selected by CentraState Healthcare System, a leading not-for-profit community health organization, to develop a strategy for transitioning to ICD-10. As part of the engagement, Cognizant will perform a comprehensive ICD-10 assessment to determine the clinical, administrative, and financial impact on business and IT processes, staff, and partners, and recommend an implementation strategy to enable a smooth transition to ICD-10 and meet the 2013 compliance deadline.

"This engagement will allow CentraState to leverage Cognizant's extensive domain, consulting, technology, and regulatory expertise to prepare for the transition to ICD-10," said Indranil Ganguly, Vice President and Chief Information Officer of CentraState. "Cognizant's end-to-end regulatory compliance capabilities and experience with multiple payer and provider organizations will help us plan our journey to ICD-10."

"We are pleased to have been selected by CentraState as a partner in this important strategic initiative," said Krish Venkat, Executive Vice President and Global Leader of Cognizant's Healthcare practice. "We look forward to working with CentraState to develop a compliance blueprint that will enable CentraState to improve care quality, optimize reimbursements, and increase physician and patient satisfaction by addressing the technical and operational implications of transition to ICD-10."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
POINT project launches video to showcase its healthcare advancements